header logo image


Page 645«..1020..644645646647..650660..»

What’s Still Left on the Shelves After All the Panic-Buying, According to People on Twitter – Our Community Now at Maryland

March 20th, 2020 8:50 pm

Courtesy of StockSnap on Pixabay

The massive panic-buying surge that stores and retailers saw across the nation has left store shelves looking like they were attacked by bears. Not all shelves are wiped clean though! There are plenty of areas of the store that are stocked up and ready to go. Wedid our share of internet sleuthing and have compiled a list of our favorite Tweets sharing what's still on the shelves.

The vegan selection seems to be going strong!

Weird hummus flavors ...

Gluten-free, anyone?

Some stores are getting creative!

Seriously, people, wash your hands!

This store, along with many others, is offering fresh baked goods with the new measure of individually wrapping everything.

Okay, people, lets not be gross.Please dont do this!

Our kind of store!

Naughty, naughty! This one is pretty funny.

Last, but not least, we can breathe a little easier knowing there is still CHOCOLATE!

Well, folks, there you have it! We may have to eat some weird tofu chocolate veggie sausage stir-fry for a while, but we can wash it down with some whiskey. Sadly, we still have no answer to the biggest shopping question right now When will there be more toilet paper?

What's the weirdest thing you have seen out there in the stores overthe last few days? Let us know in the comments, and again, if anyone knows where to get toilet paper, please let everyone in on your secret!

Excerpt from:
What's Still Left on the Shelves After All the Panic-Buying, According to People on Twitter - Our Community Now at Maryland

Read More...

The coronavirus is killing far more men than women. But why? – Boston.com

March 20th, 2020 8:50 pm

With more than 200,000 coronavirus cases worldwide and thousands of deaths, a striking pattern is appearing in the hardest-hit countries: More men are dying than women.

No where is this trend more pronounced than in Italy. Men make up nearly 60% of people with confirmed cases of the virus and more than 70% of those who have died from covid-19, according to the countrys main public health research agency.

On the other end of the spectrum is South Korea, where about 61% of confirmed infections have been in women. Though far fewer patients have died, the majority of fatalities 54% were again in men.

As the pandemic escalates, epidemiologists and public health authorities are scrambling to understand who is most vulnerable and how to protect them. The data from countries such as Italy and South Korea show that the disease can take wildly different paths.

Exactly what makes a group vulnerable and how to protect them has experts mystified, said Carlos del Rio, chair of the department of global health at Emory University. This difference in mortality is creating a lot of anxiety, he added.

The outbreak of covid-19 in Italy is the deadliest in the world. As of March 17, more than 40,000 people there have been sickened with the virus, and 3,405 have died. That means that, based on these current and unavoidably incomplete figures, 8.2 percent of people infected in the country have died. That is more than double the global figure presented recently by the WHO.

Italys aging population is probably particularly susceptible to the disease, researchers say. With a median age of 46.5, according to the CIA World Factbook, it is the fifth oldest country in the world. And these elderly citizens are those who have become the sickest: People over the age of 70 represent more than 87% of deaths there.

Older people are typically hit harder with respiratory diseases, del Rio said. They are more likely to get pneumonia an infection that inflames the lungs and fills them with fluid or pus and to have underlying health conditions that could make them vulnerable to the virus.

With older people, del Rio said, sometimes it doesnt take very much to push you over the edge.

The gender disparity in illness and death is harder to explain. Even before the covid-19 pandemic reached Italy, early reports out of China suggested men were especially at risk. A study of 99 patients at a hospital in Wuhan, where the virus originated, found that men made up two-thirds of patients, and half of all the people who were hospitalized had chronic conditions such as heart disease or diabetes. More recent figures from Chinas Center for Disease Control, based on tens of thousands of cases, showed a strong gender breakdown of deaths, which were 64% male.

But the figures in Italy have been even more staggering. Nearly 60% of diagnoses have been in men, according to Italys top health research agency, Istituto Superiore di Sanit. Across the first 1,697 coronavirus deaths, 71% 1,197 were in men. Just 29%, or 493, were in women.

In a recent study published in the Lancet, meanwhile, the figures were even higher. It found that 80% of the deaths were in men and just 20% were in women.

It is certainly possible that as death tolls rise in other countries, the pattern of greater male deaths seen so far in Italy, China, and South Korea could shift. But so far, this is what the evidence shows in the two countries with the largest death tolls, Italy and China, and in a third country (South Korea) acclaimed for keeping very good tabs on the disease.

The honest truth is that today we dont know why covid-19 is more severe for men than women or why the magnitude of the difference is greater in Italy than China, said Sabra Klein, a professor at Johns Hopkins Bloomberg School of Public Health. What we do know is that in addition to older age, being male is a risk factor for severe outcome and the public should be made aware.

The gendered death gap was also seen in the smaller SARS and MERS outbreaks, added Angela Rasmussen, a virologist at Columbia University.

Its clearly something that has happened consistently with coronaviruses, it could inform clinical practices and improve patient outcomes, and its definitely a question worth investigating, she added.

These statistics could be a product of behavior, biology, or both, scientists say.

For one thing, demographic figures suggest many men have more health risks to begin with. In China, Italy and South Korea, women tend to live longer than men, according to the World Health Organization.

Men also drink and smoke more in all of these countries, particularly in China, where 48% of men above 15 smoke compared with just 2% of women, according to the WHO. Probably not coincidentally, men in these countries also tend to die more frequently from heart disease, cancer, diabetes and respiratory diseases between ages 30 and 70.

But there are also underlying biological differences between men and women that may make covid-19 worse in men, several researchers pointed out. Years of research have found that women generally have stronger immune systems than men and are better able to fend off infections. The X chromosome contains a large number of immune-related genes, and because women have two of them, they gain an advantage in fighting disease, according to a recent study in the journal Human Genomics. Studies have also found that estrogen was protective in female mice infected with the virus that caused the 2003 SARs outbreak. During that epidemic, men had a much higher case fatality rate than women.

When [a] severe outcome is caused by an inability to rapidly control the infection, then it is often adult males who suffer worse outcomes than females, Klein wrote in an email.

South Korea presents a stark contrast to Italy. Rapid action by public health authorities, who have administered coronavirus tests at a higher rate than any other country in the world, has slowed the spread of the outbreak there. As of March 19, the country had 8,565 confirmed cases and 91 deaths. As a result, its current case fatality rate of 1.06% is far below the global average.

That low death rate is testament to the countrys aggressive coronavirus response; Korean hospitals were not overloaded, as they are in Italy, and life treatment centers were set up for patients with milder symptoms.

But it is also a function of who is getting sick, del Rio said. Whereas the typical coronavirus patient in Italy and elsewhere is male and in his 60s, women represent more than 60% of infections in South Korea, and nearly a third of the cases there have been people between the ages of 20 and 29.

What were beginning to see is that the disease presents in multiple ways and its pretty mild in people who are young, del Rio said.

Young women are overrepresented in South Koreas coronavirus patient figures because of the demographics in the fringe religious sect Shincheonji Church of Jesus, where the countrys biggest coronavirus cluster took place.

South Korea saw a sudden spike in virus cases after an infection cluster emerged at a local branch of the church mid-February. Later that month, South Korean health authorities launched a testing blitz on more than 200,000 members of the church across the country.

In a briefing earlier this month, the countrys center for disease control director Jung Eun-Kyeong said the number of young female patients is high because women in their 20s and 30s make up a big portion of Shincheonji church membership.

Experts say the mass testing of the church members possibly gave rise to detection bias in epidemiological statistics surrounding South Koreas coronavirus outbreak.

If you test all members of a church the likelihood of disease detection in that group naturally goes up, said Choi Jae-wook, professor of Preventative Medicine at Korea University in Seoul. The skewed representation of young patients from the church cluster helped make South Koreas case fatality rate so low, Choi said.

It may be that more young people are getting sick in Italy as well, but because their symptoms are mild and the country has not been testing aggressively, those cases are not being counted, del Rio said.

The age and gender discrepancies could offer important insights into how the coronavirus interacts with hosts immune systems, said Andrew Pekosz, a virologist at Johns Hopkins. Symptoms like high fever and a bad cough suggest the virus triggers an extreme inflammatory response, in which the body counters attacks with an army of defensive cells.

Sometimes it can be those cells that are driving the disease, Peskov said, causing more damage than they are controlling infection.

Understanding this response, particularly as it unfolds differently in different demographics, may help researchers develop treatments, he added.

But Harlan Krumholz, a professor of cardiology and outcomes research at Yale Medical School, cautioned that comparing countries is a tricky endeavor. We dont know numerators or denominators. The information is not comparable, he said.

He said that the best information was probably from South Korea, because it tested so many people. Everywhere else is biased, he said, depending on who is doing the testing, who is considered severe enough to be hospitalized and how you determine whether a death is related to the virus or not.

He worries that insufficient data is hampering doctors, scientists and public officials, making it more difficult to have a real-time understanding of the extent of the disease and the most effective ways to respond.

We should be able to do this, he said. This is revealing our great ignorance in the midst of an information age.

Kaplan and Mooney reported from Washington Andy Kim from Seoul. Steven Mufson in Washington contributed to this report.

See the original post:
The coronavirus is killing far more men than women. But why? - Boston.com

Read More...

‘Raise the line’: Osmosis videos educate the public and medical community on COVID-19 – Technical.ly DC

March 20th, 2020 8:50 pm

From actions to take to stop COVID-19 from spreading to the importance of flattening the curve, theres a lot to learn about infectious diseases these days.

As a health education company, Osmosis puts together videos and other learning content thats designed to be approachable. Alongside a platform designed for medical students and healthcare professionals, the company founded by former Johns Hopkins med school students has drawn an audience of more than 1.4 million subscribers for its widely available animated videos on YouTube.

So it makes sense that when COVID-19 began to spread, they created videos to explain the new disease. Its now become a package designed to provide public information, debunk myths and educate workers in healthcare.

Given that its a new virus and more is being learned all the time, Osmosis Chief Medical Officer Dr. Rishi Desaisaid the team took a distinct approach. Over the last three months, the team has been updating the videos with fresh knowledge, as well as adding new videos that provide education on general topics like how to clean surfaces, and clinic-specific instruction like how to wear N95 masks correctly.

Each of these updated videos carries with it key things you have to know, but we also try to address, What are the relevant things that people are hearing about right now in the news cycle? and add that squarely in the video, Desai said.

Theyre also putting out social media infographics to get at some of the more nuanced points of the crisis. For instance, they observed in Wuhan, China, that the actions taken to enforce social distancing didnt have an immediate effect on the number of rising cases. But results started to show two weeks later.

You can imagine someone with less resolve would say, OK, lets trying something else. For two long weeks they stuck with it and finally it started trailing off, Desai said.

It could be especially instructive for the U.S., where actions are being taken by governments even as cases are rising.

Weve seen this before. We know this is what happens, so lets share that through an infographic, he said.

It also means introducing new terms. Along with flattening the curve, Osmosis also has a video on how to raise the line, which goes over the importance of adding capacity in the healthcare system to treat an expected influx of patients through telemedicine and minimizing elective procedures.

In the realm of answering questions directly, Desai held Ask Me Anything sessions on YouTube that drew global inquiries.

A pediatric infectious disease physician who previously led Khan Academy Medicine, Desai was the fifth employee to join Osmosis. Previously, he worked as an epidemic intelligence officer at the Centers for Disease Control. In that role, he investigated outbreaks and how they spread by donning protective gear to seek out patients who had symptoms and tracing their contact history.

Given the past experience, Technical.ly asked about a prime public health message that folks should hear right now to help. He said the old adage, Dont just stand there, do something, is now turned on its head.

To stop the spread, now its Dont just do something, stand there, he said: The more people keep moving around, keep socializing or going to that one little gathering, it does put everyone at more and more risk.

Go here to see the original:
'Raise the line': Osmosis videos educate the public and medical community on COVID-19 - Technical.ly DC

Read More...

We have been here before: A century before coronavirus, Hampton faced the Spanish flu – Seacoastonline.com

March 20th, 2020 8:50 pm

As the coronavirus becomes an ever-increasing discussion in our daily lives let us consider how Hampton in the past hunkered down to wait out the passing of epidemics and pandemics before the age of Wi-Fi, TV and social distancing and who was it who took care of the sick.

The doctors of Hampton played a key role in the community at all times but especially during a medical crisis; a broken bone, accident, mysterious death, pandemic outbreak, they would bring the needed comfort and confidence to those in distress.

Ill-equipped, with just his medical bag, no Spectra Shield Respirator mask from Foss Manufacturing, no Purell, special drugs, antibiotics, or even toilet paper (TP was invented in 1857 but was expensive so people preferred the Sears and Roebuck catalogue, a corn cob or a linen cloth), the doctor would enter the patients home to see if he could evaluate and help. He might have some Laudanum in his bag to ease the pain but not much more. At the end of the day, he would water his horse at the town pump on Exeter Road and perhaps finally wash his hands, minus soap and hot water, after a busy day. He would have probably visited with 50 patients in a day.

Dressed in a suit, tie and hat, Dr. Marvin Fisher Smith drove his buggy on the unpaved roads of Hampton to reach out to his patients. He came to Hampton in 1888 and died in 1916 before the Spanish flu pandemic hit Hampton and the world; but he would witness and administer to the Diphtheria epidemic of 1890-91 that closed schools, churches and meetings to contain the disease. He would come down with the disease himself but recover, later campaigning for vaccinations against disease. Through his efforts, Hampton preschools were inoculated as an annual ritual of preventative medicine.

In March of 1918, the Spanish flu pandemic hit the town of Hampton. Throughout the spring and summer cases of the flu were intermittent with no reported deaths but by Oct. 10, health officer Frank Long postponed all public meetings including schools, churches, and organizations with a large membership. There were a reported 200 people who became sick, many died in the town and beach. For most, the disease would last three days and deaths were usually from secondary infections like pneumonia. The well-liked pharmacist Victor G. Garland succumbed at 27 to the influenza after a heroic struggle, so too did Lottie Mace Reilly, George Storrow Ireland, and Mr. Warren M. Batchelder.

The Hampton Union reported that the epidemic of influenza seems to be under control. The ban on public meeting will be lifted on October 28, 1918.

At this time, Dr. E. Henry Thompson and Dr. Stanley M. Ward were the horse and buggy doctors of Hampton. There were two nurses hired by the town to assist the doctors during the flu pandemic.

As the flu pandemic raged in 1918, Hampton had a population of about 1250 people, the automobile was just beginning to share the roads with the horse and buggy, men and women were traveling around the country and to Italy and France to help with the war effort, and although the railroad did bring outsiders to the community there were not so many worldwide connections as there are today.

In Hampton 2020, the population is approximately 14,000. We are connected to the world and our borders are open, for the most part to all. We travel worldwide and love to meet in large numbers to cheer on our sports teams. We are a social body of people who like to shake hands and have close connections with each other.

A pandemic virus moves, silently and quickly. This one, coronavirus, targets the elderly and compromised. The Diphtheria epidemic and Spanish flu pandemic tended to attack the young but in the long run viruses do not discriminate.

In 1918, closures in the town lasted only a few weeks. A year later the town was celebrating the end of the war with large gatherings and parades to celebrate the end of WW1.

We too will weather this medical emergency as a community with the help of doctors, medicine, good decisions by our leaders and all of us doing our part.

We learn from the past that history does matter and although we are experiencing this trial under different circumstances from the pandemics and epidemics of the past, we as they were, are all in this together.

Take the time to evaluate for the future. Help others that are in need and be kind to each other.

If you wish to watch the video Hampton Voices from WW1 that documents a section about the 1918 Spanish flu pandemic, visit http://www.hamptonhistoricalsociety.org to view the video on YouTube.

Read the original:
We have been here before: A century before coronavirus, Hampton faced the Spanish flu - Seacoastonline.com

Read More...

Are supplements worth it? – Health and Happiness – Castanet.net

March 20th, 2020 8:50 pm

Photo: Contributed

Forty-five per cent of Canadians regularly take health products, such as vitamins, minerals or herbal remedies.

With annual sales at an estimated $1.4 billion in Canada, I ask:

A recentUniversity of Toronto study looked into the evidence supporting the use of supplements, such as vitamins, minerals and fish oils. Specifically, the study looked at the effect on the risk of heart-related illness.

It foundthere was no significant effect from taking supplements.Supplements dont help to prevent cardiovascular disease, and they come at a cost.

I take a look at the main vitamins and nutrients, and how you can ensure youre getting enough without paying excessively for the benefits.

The government only recommends a few supplements, depending on age. Vitamin D is recommended for all Canadians, because most of us are deficient due to a lack of sun exposure.

Vitamin D helps regulate the amount of calcium and phosphate in the body, and is needed to keep bones, muscles and teeth healthy.

Being deficient in vitamin D can lead to rickets in children, which is a type of bone deformity. In adults, it can cause a condition called osteomalacia, which is a softening of the bones.

During summer, we should be able to get all the vitamin D we need from sunlight. However, as most Canadians are deficient in this vitamin, taking an oral supplement is a good idea.

Vitamin A and C are also recommended for children aged six months to five years old. Vitamin A helps your bodys natural defences, including keeping skin healthy, while vitamin C also helps maintain healthy skin, bone and blood vessels.

Eating a balanced diet full of fruit, vegetables and dairy (or alternatives fortified with vitamins), should ensure that you get all the vitamin A and C needed.

The recommendation to supplement childrens diets is due to the fact that more vitamin A and C are needed for growth and development.

Women trying for a baby, or in the first 12 weeks of pregnancy, are recommended to take folic acid. This nutrient is important in the development of the brain and spinal cord in Fetuses.

Aside from pregnancy, there is no clinical need or benefit to taking folic acid, so it isnt recommended for anyone outside this category.

Other nutrients, such as calcium and iron, are also marketed by pharmaceutical companies as being essential to your health and well being.

While this is true calcium building strong bones, muscles and teeth, and iron essential for carrying oxygen around the body we should be reaching our daily targets if we eat a healthy, balanced diet.

Good sources of iron include meat, liver, beans, nuts, whole grains and green vegetables.

Women need more iron than men due to having periods and losing blood each month. Signs of iron deficiency anemia include feeling tired, out of breath or weak.

If you believe you may be deficient, go to your family doctor to get your blood levels checked.

Taking iron supplements without medical supervision isnt advised; iron can cause nasty side effects.

Calcium is also found in similar foods, as well as dairy products (or fortified alternatives). Taking too much calcium, in the form of supplements, can cause stomach pain and diarrhea, so again is not recommended without a physicians advice.

A few years ago, I challenged myself to eat the Daily Dozen a checklist of 12 types of food that you should incorporate into your diet each day.

I downloaded the app (Dr. Gregers Daily Dozen) and aimed to tick off all the food groups by the end of the day.

This is a great way of making sure youre getting all the right vitamins and nutrients to stay fit and healthy!

The list is as follows:

Download the app, or read of Dr. Gregers book, How Not to Die. Its a really informative read about how to use diet and exercise to prevent all the top causes of death.

Get in touch in the comments below, or via email, if you have any questions about supplements or how to reach your daily targets.

View original post here:
Are supplements worth it? - Health and Happiness - Castanet.net

Read More...

Coronavirus: EU head hopes for Covid-19 vaccine by autumn – The National

March 20th, 2020 8:50 pm

The European Commission president has said she hopes a vaccine for coronavirus could be ready before the autumn as the bloc puts aside bureaucratic obstacles and races with the US and other geopolitical rivals to tackle the crisis.

Ursula von der Leyen, a former medical doctor, has said a vaccine against the novel coronavirus, known as Covid-19, could be prepared much faster in the face of the global pandemic.

Health authorities have said, however, that it would take another 18 months before the preventative medicine could be put on the market.

The EU has offered CureVac, a biopharmaceutical company headquartered in Tubingen, Germany, 80 million euros to develop a new vaccine to create immunity against Covid-19. The company has said it could begin trails with humans as early as June.

I hope that with this support, we can have a vaccine on the market, perhaps before autumn, Ms Von der Leyen said.

"As we are in a severe crisis, we all see that we are able to speed up any of the processes that are slow normally and take a lot of time and are very bureaucratic," Ms Von der Leyen told reporters later on Tuesday.

Representatives for CureVac have said a vaccine could be ready in time if the German regulator allowed it to fast-track its product. Developing a shot before the autumn would allow nations the opportunity to stop a second seasonal wave of the virus in its tracks.

However, national heath advisors across Europe and the United States have regularly warned a vaccine could not be prepared before the end of 2020.

Curevac has found itself at the centre of a spat between Europe and the United States after reports emerged in the German press that a US official had offered to pay for the rights to the Covid-19 vaccine.

A White House official was reported to have offered large sums of cash for the vaccine on the provision that it was only for the USA.

The biotech company has subsequently had to deny reports that the administration of US President Donald Trump had tried to get hold of the vaccine.

"There was and there is no takeover offer from the White House or governmental authorities. Neither to the technology nor to CureVac at all as a company," CureVac acting CEO Franz-Werner Haas said on Tuesday.

However it has emerged that the US airforce flew 500,000 COVID-19 testing kits from Italy on a C-17 transporter to Tennessee on Monday as Washington uses its resources to fight the spread of the virus within its borders.

At the same time, specialist doctors and medical equipment have arrived in Italy ready to help tackle the sharp spike in people with the disease, which has overwhelmed medical facilities.

The doctors bring with them first-hand experience of dealing with the coronavirus, having previously helped to tackle the original outbreak in China's Hubei province that killed more than 3,000 people. Tough quarantine measures have seen the rate of new cases in China dwindle, while in Europe the outbreak continues to spread.

Updated: March 19, 2020 01:39 AM

Read more from the original source:
Coronavirus: EU head hopes for Covid-19 vaccine by autumn - The National

Read More...

FDA Urged to Approve Chloroquine to Treat COVID-19 – Breitbart

March 20th, 2020 8:50 pm

President Donald Trump said Thursday his administration willmake the malaria drug chloroquine available almost immediately to treat the COVID-19 infection, but it will only be available under the compassionate use program until the drug undergoes a clinical trial under the FDAs directive.

Studies are showing chloroquine can both prevent and treat coronavirus in the cells of primates, but it is not FDA-approved for COVID-19.

Some doctors report very encouragingresults quickly in very sick people, Dr. Jane Orient, executive director of the Association of American Physicians and Surgeons, told Breitbart News about research into chloroquine to treat the COVID-19 also known as SARS-CoV-2 respiratory illness.

Independent doctorsmay prescribe it off-label, but employed physicians might not be allowed to, by corporate administrators, because it is not FDA-approved for this indication, she added. No preventive or therapeutic meds are specifically approved for this.

As Breitbart Newss James Delingpole observed, a study document prepared by Dr. James Todaro and Attorney Gregory Rigano, in association with Stanford University School of Medicine and National Academy of Sciences Researchers, concluded:

Chloroquine can both prevent and treat malaria. Chloroquine can both prevent and treat coronavirus in primate cells (Figure 1 and Figure 2). According to South Korean and China human treatment guidelines, chloroquine is effective in treating COVID-19. Given chloroquines human safety profile and existence, it can be implemented today in the U.S., Europe and the rest of the world. Medical doctors may be reluctant to prescribe chloroquine to treat COVID-19 since it is not FDA approved for this use. The United States of America and other countries should immediately authorize and indemnify medical doctors for prescribing chloroquine to treat COVID-19. We must explore whether chloroquine can safely serve as a preventative measure prior to infection of COVID-19 to stop further spread of this highly contagious virus.

The Centers for Disease Control and Prevention (CDC) states:

Chloroquine is an antimalarial medicine available in the United States by prescription only Chloroquine can be prescribed for eitherprevention or treatmentof malaria. Chloroquine can be prescribed to adults and children of all ages. It can also be safely taken by pregnant women and nursing mothers.

Dr. Martin J. Vincent, et al, also wrote in 2005 in a study published at the National Institutes of Health (NIH) when severe acute respiratory syndrome (SARS) was found to have been caused by coronavirus SARS-CoV:

Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available.

We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage. In addition to the well-known functions of chloroquine such as elevations of endosomal pH, the drug appears to interfere with terminal glycosylation of the cellular receptor, angiotensin-converting enzyme 2. This may negatively influence the virus-receptor binding and abrogate the infection, with further ramifications by the elevation of vesicular pH, resulting in the inhibition of infection and spread of SARS CoV at clinically admissible concentrations.

The researchers concluded that chloroquine is effective in preventing the spread of SARS CoV in cell culture.

Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection, they added.

The nice part is its been around for a long time, so we know that if things dont go as planned, its not going to kill anybody, Trump said at a press briefing.

Nevertheless, Dr. Stephen M. Hahn, commissioner of food and drugs at the Food andDrug Administration (FDA), wrote at USA Today Tuesday:

While the Food and Drug Administration is working full speed, in collaboration with public and private sector partners, to help diagnose, treat and prevent this disease, presently there are no FDA-approved products to prevent, treat or cure COVID-19.

Orient said:

We need to get the FDA out of the practice of medicine. Also, it can shut down U.S. productionlines for exceeding production quotas or aminor paperwork violation, but has no meaningful inspection ofplants in China, on which we are dependent for 90% of our drug supply, including antibiotics and other things needed to care for critically ill patients.

Hopefully the Trump administration is working on bringing essential manufacturing home, she concluded.

Meanwhile, Orient recommends that those with a fever only treat it after consultation with a doctor:

Fever is not a disease. It is an important defense mechanism. Very high fevers (say 105 degrees) can cause brain damage, and children can have seizures. But dont pop Tylenol or ibuprofen at the first sign of fever. Many of the casualties in the 1918 pandemic might have been caused by heavy use of aspirin. Like aspirin, popular nonsteroidal anti-inflammatories (NSAIDS), such as ibuprofen, also have detrimental effects on blood clotting. Try lukewarm sponge baths for comfort.

Orient recommends that Americans only go to an emergency room or urgent care facility if they are severely ill. She explained:

There will be sick people there, and you might catch something. You also might end up with a big bill, say for a CT scan you didnt really need. And if you have the flu or a cold or COVID-19, and dont need IV fluids or oxygen, they cant do anything for you.

At home, Orient advises families to clean and disinfect surfaces such as doorknobs, telephones, computer keyboards, toilets, and countertops often.

Virus can persist there for days, she says.

She also urges Americans to ensure they are getting the vitamins they need.

Most people may be vitamin D deficient, she explains. Your need for vitamin C escalates with infection. Some 50 tons of vitamin C was shipped to Wuhan, and studies of effectiveness are underway.

See the rest here:
FDA Urged to Approve Chloroquine to Treat COVID-19 - Breitbart

Read More...

New academic study reveals over-the-counter anti-malaria med Chloroquine may be highly effective at treating coronavirus – TechStartups.com

March 20th, 2020 8:50 pm

Update: Wednesday, March 18, 2020New controlled clinical study conducted by doctors in France shows that Hydroxychloroquine cures 100% of coronavirus patients within 6 days of treatment (covidtrial.io)

The coronavirus pandemic has so far claimed7,171 lives, with at least 182,603coronavirus cases reported and79,881 people recovered. Today, the NIH begins clinical trial of investigational vaccine for COVID-19. While the trial launched in record speed, public health officials have been stressing for weeks that a vaccine wont be ready for 12 to 18 months in the best circumstances.

However, there is good news today that an existing anti-viral medication may be effective at treating the COVID-19. According to anew academic studypresented by Thomas R. Broker, (Stanford PhD), James M. Todaro (Columbia MD), and Gregory J. Rigano, Esq., in consultation with Stanford University School of Medicine, UAB School of Medicine, and National Academy of Sciences researchers, shows that over the counter anti-malaria pills Chloroquine may be highly effective at treating coronavirus COVID-19.

In a research work published on Friday, recent guidelines from South Korea and China report that chloroquine is an effective antiviral therapeutic treatment against Coronavirus Disease 2019. Use of chloroquine (tablets) is showing favorable outcomes in humans infected with Coronavirus including faster time to recovery and shorter hospital stay. US CDC research shows that chloroquine also has strong potential as a prophylactic (preventative) measure against coronavirus in the lab, while we wait for a vaccine to be developed. Chloroquine is an inexpensive, globally available drug that has been in widespread human use since 1945 against malaria, autoimmune and various other conditions, the authors said.

According to research by the US CDC, chloroquine has strong antiviral effects on SARS coronavirus, both prophylactically and therapeutically. SARS coronavirus has significant similarities to COVID-19. Specifically, the CDC research was completed in primate cells using chloroquines well known function of elevating endosomal pH. The results show that We have identified chloroquine as an effective antiviral agent for SARS-CoV in cell culture conditions, as evidenced by its inhibitory effect when the drug was added prior to infection or after the initiation and establishment of infection. The fact that chloroquine exerts an antiviral effect during pre- and post-infection conditions suggest that it is likely to have both prophylactic and therapeutic advantages.

Background

The U.S. CDC and World Health Organization have not published treatment measures against Coronavirus disease 2019 (COVID-19). Medical centers are starting to have issues with traditional protocols. Treatments, and ideally a preventative measure, are needed. South Korea and China have had significantly more exposure and time to analyze diagnostic, treatment and preventative options. The U.S., Europe and the rest of the world can learn from their experience. According to former FDA commissioner, board member of Pfizer and Illumina, Scott Gotlieb MD, the world can learn the most about COVID-19 by paying closest attention to the response of countries that have had significant exposure to COVID-19 before the U.S. and Europe.[1]

As per the U.S. CDC, Chloroquine (also known as chloroquine phosphate) is an antimalarial medicine Chloroquine is available in the United States by prescription only Chloroquine can be prescribed for either prevention or treatment of malaria. Chloroquine can be prescribed to adults and children of all ages. It can also be safely taken by pregnant women and nursing mothers.[2]

CDC research also shows that chloroquine can affect virus infection in many ways, and the antiviral effect depends in part on the extent to which the virus utilizes endosomes for entry. Chloroquine has been widely used to treat human diseases, such as malaria, amoebiosis, HIV, and autoimmune diseases, without significant detrimental side effects.[3]

The treatment guidelines of both South Korea and China against COVID-19 are generally consistent, outlining chloroquine as an effective treatment.

Specifically, according to the Korea Biomedical Review, in February 2020 in South Korea, the COVID-19 Central Clinical Task Force, composed of physicians and experts treating patients agreed upon treatment principles for patients with COVID-19.[4] In China, the General Office of the National Health Commission, General Office of the State Administration of Traditional Chinese Medicine as well as a Multi-Center Collaborative Group of Guangdong Provincial Department of Science and Technology and Guangdong Provincial Health Comp and the China National Center for Biotechnology Development have established effective treatment measures based on human studies.[5]

Data from the drugs [chloroquine] studies showed certain curative effect with fairly good efficacy patients treated with chloroquine demonstrated a better drop in fever, improvement of lung CT images, and required a shorter time to recover compared to parallel groups. The percentage of patients with negative viral nucleic acid tests was also higher with the anti-malarial drug Chloroquine has so far shown no obvious serious adverse reactions in more than 100 participants in the trials Chloroquine was selected after several screening rounds of thousands of existing drugs. Chloroquine is undergoing further trials in more than ten hospitals in Beijing, Guangdong province and Hunnan province.[6]

According to the Korea Biomedical Review, the South Korean COVID-19 Central Clinical Task Force guidelines are as follows:

1. If patients are young, healthy, and have mild symptoms without underlying conditions, doctors can observe them without antiviral treatment;

2. If more than 10 days have passed since the onset of the illness and the symptoms are mild, physicians do not have to start an antiviral medication;

3. However, if patients are old or have underlying conditions with serious symptoms, physicians should consider an antiviral treatment. If they decide to use the antiviral therapy, they should start the administration as soon as possible:

chloroquine 500mg orally per day.

4. As chloroquine is not available in Korea, doctors could consider hydroxychloroquine 400mg orally per day (Hydroxychloroquine is an analog of chloroquine used against malaria, autoimmune disorders, etc. It is widely available as well).

5. The treatment is suitable for 7 10 days, which can be shortened or extended depending on clinical progress.

Notably, the guidelines mention other antivirals as further lines of defense, including anti-HIV drugs.

According to Chinas Novel Coronavirus Pneumonia Diagnosis and Treatment Plan, 7th Edition, the treatment guidelines are as follows:

1. Treatment for mild cases includes bed rest, supportive treatments, and maintenance of caloric intake. Pay attention to fluid and electrolyte balance and maintain homeostasis. Closely monitor the patients vitals and oxygen saturation.

2. As indicated by clinical presentations, monitor the hematology panel, routine urinalysis, CRP, biochemistry (liver enzymes, cardiac enzymes, kidney function), coagulation, arterial blood gas analysis, chest radiography, and so on. Cytokines can be tested, if possible.

3. Administer effective oxygenation measures promptly, including nasal catheter, oxygen mask, and high flow nasal cannula. If conditions allow, a hydrogen-oxygen gas mix (H2/O2: 66.6%/33.3%) may be used for breathing.

4. Antiviral therapies:

chloroquine phosphate (adult 18-65 years old weighing more than 50kg: 500mg twice daily for 7 days; bodyweight less than 50kg: 500mg twice daily for day 1 and 2, 500mg once daily for day 3 through 7)

Additionally, the Guangdong Provincial Department of Science and Technology and the Guangdong Provincial Health and Health Commission issued a report stating Expert consensus on chloroquine phosphate for new coronavirus pneumonia: clinical research results show that chloroquine improves the success rate of treatment and shortens the length of patients hospital stay.[9] The report further goes on to cite research from the US CDC from 2005 as well as research from the University of Leuven University in Belgium regarding chloroquines effectiveness against SARS coronavirus at the cellular level.[10]

Like the South Korean guidelines, notably, other antivirals (e.g. anti-HIV drugs) are listed as further lines of defense. The most research thus far has been around chloroquine.

Chloroquine as a prophylactic (preventative) measure against COVID-19[11]

According to research by the US CDC, chloroquine has strong antiviral effects on SARS coronavirus, both prophylactically and therapeutically. SARS coronavirus has significant similarities to COVID-19. Specifically, the CDC research was completed in primate cells using chloroquines well known function of elevating endosomal pH. The results show that We have identified chloroquine as an effective antiviral agent for SARS-CoV in cell culture conditions, as evidenced by its inhibitory effect when the drug was added prior to infection or after the initiation and establishment of infection. The fact that chloroquine exerts an antiviral effect during pre- and post-infection conditions suggest that it is likely to have both prophylactic and therapeutic advantages.

In conclusion, the study shows that chloroquine is effective in preventing SARS-CoV infection in cell culture if the drug is added to the cells 24 h prior to infection.

You can read the rest of the report here.

Read more from the original source:
New academic study reveals over-the-counter anti-malaria med Chloroquine may be highly effective at treating coronavirus - TechStartups.com

Read More...

Lessons from South Korea on Covid-19 preventive measures – The East African

March 20th, 2020 8:50 pm

By AGGREY MUTAMBOMore by this Author

Authorities in South Korea have rued the missed chance they had in arresting the surge of coronavirus cases in their country, when they let a suspected patient walk back to her community.

By Tuesday this week, South Koreas Centres for Disease Control had reported 8,320 cases of Covid-19, 81 deaths and 1,401 fully recovered patients.

Though Seoul reported its first case of Covid-19 on January 20, officials say it shouldnt have spread this way.

It all began on February 18, when a woman only identified as Patient 31 checked into a South Korean hospital displaying symptoms associated with the new coronavirus. But the woman reportedly refused to take a Covid-19 test even after her doctor advised it.

It turned out she was a member of the Shincheonji, Church of Jesus, the Temple of the Tabernacle of the Testimony (SCJ), a highly secretive sect in South Korea and which the Korean CDC says two thirds of the Covid-19 cases in the country are associated with.The woman, 61, came from Daegu, a city in South Korea with about 2.5 million people, where the church has a significant following.

South Korean officials say the woman initially refused to take the test as she feared it could lead to her revealing her church members. She also insisted that she had not travelled overseas and had not contacted an infected person. The woman would later be forced back to the hospital after her condition became worse. But she had infected many more of her church members.The Church, began in 1984 by leader Lee Man-hee, who is seen as the only interpreter of the Book of Revelations, follows some secretive practices including keeping their membership to themselves. The Korean CDC, however, found the church had a branch in Wuhan in China, where the virus was first reported, and some members had travelled from there recently.

Inside South Korea, their members prayed close to each other, operated in secrecy, and accessed the church using a finger-print reading system. And as each member placed a finger on the same surface, it is possible the virus spread among members, before spreading to nearby communities. All this time, Korean authorities were legally barred from interfering with freedom of worship. Three days after Patient 31 showed up in hospital, South Koreas cases reached 346, becoming the biggest incidences reported outside China then.Korean officials last week reported more recoveries than infections. The country largely depended on lessons learnt from the missed opportunity, according to a report by the local CDC.The Churchs officials put out a statement denying they hindered preventive measures.

Controlling and preventing infectious diseases is a serious matter which is directly related to the health of people and may cause social anxiety from concerns of infection. The church is assisting in thorough investigation and diagnosis following the instructions of the health department, the Church says on a statement on its website.Whether their practices hindered prevention or not, reflects how deep religious beliefs and misinformation about medical facts may hinder combating the virus.

In east Africa, where coronavirus cases have risen, experts warned misinformation or dangerous beliefs could be just as harmful.

In Kenya, for example, authorities have in the past used force to implement some medical programmes like polio immunisation, especially in communities that follow stringent religious beliefs against medication. Others choose to believe their deities rather than advice from medical experts.

It appears to be in our nature to consistently appeal to supernatural forces whenever faced with a serious threat instead of taking practical measures to deal with emergent threats, Sunday Nation columnist Lukoye Atwoli, an associate professor of psychiatry at Moi University School of Medicine, said in his column.When it comes to public health, it is important to understand the science behind a problem in order to be able to control it.

In Korea, authorities began a programme where motorists can drive through a centre, give samples and be contacted later in case they test positive. That has helped reduce the rates of infections.

An analysis by the Poynter Institute last week found a series of misinformation concerning religion and races, where false purveyors claimed some religions can be good shields against Covid-19.

Religion is not a way to protect yourself against the new disease, the Institute observed.

These beliefs can keep infected people away from real treatment, and those who are at risk of contamination far from preventative measures, promoting real harm.Last year, the World Health Organisation had to appeal to Facebook to flag false information about vaccines, after the global health body was met with rising advocates against immunisation.

WHO Director-General Dr Tedros Adhanom Ghebreyesus said, Vaccine misinformation is a major threat to global health that could reverse decades of progress made in tackling preventable diseases.

Many debilitating and deadly diseases can be effectively prevented by vaccines. Think measles, diphtheria, hepatitis, polio, cholera, yellow fever, influenzaCovid-19 doesnt have a vaccine yet, but Dr Tedros admitted recently that misinformation about the virus was still a challenge.

In East Africa though, officials have also been pushed to advise against cash to prevent potential spread of the coronavirus pandemic.

Someone like a tout who collects cash all the time should put on disposable gloves, said Dr Diana Atwine, Ugandas Permanent Secretary in the Ministry of Health, in a series of public awareness tweets on Monday.

Money has been proven to be a great source of infections, she said.

In Nairobi, President Uhuru Kenyatta called on vendors to facilitated use of non-cash payments. But all the East African countries use public transport systems where service providers largely accept cash payments.

See the rest here:
Lessons from South Korea on Covid-19 preventive measures - The East African

Read More...

Deaths climb to 4 in Illinois, Pritzker says grocery stores, interstates will never shut down – Alton Telegraph

March 20th, 2020 8:50 pm

A public service announcement about coronavirus prevention is displayed on an electronic traffic message board as an ambulance travels northbound on Chicagos Dan Ryan Expressway, Thursday, March 19, 2020. (AP Photo/Charles Rex Arbogast)

A public service announcement about coronavirus prevention is displayed on an electronic traffic message board as an ambulance travels northbound on Chicagos Dan Ryan Expressway, Thursday, March 19, 2020.

A public service announcement about coronavirus prevention is displayed on an electronic traffic message board as an ambulance travels northbound on Chicagos Dan Ryan Expressway, Thursday, March 19, 2020. (AP Photo/Charles Rex Arbogast)

A public service announcement about coronavirus prevention is displayed on an electronic traffic message board as an ambulance travels northbound on Chicagos Dan Ryan Expressway, Thursday, March 19, 2020.

Deaths climb to 4 in Illinois, Pritzker says grocery stores, interstates will never shut down

SPRINGFIELD As Gov. JB Pritzker announced three more COVID-19-related deaths and 134 new confirmed cases Thursday, he also expressly asserted that interstate highways, gas stations, grocery stores and other essential services will not close as a response to the pandemic.

I want to address some of the rumors that have been running around, Pritzker said. Essential services will not close. Interstates, highways and bridges will stay open. Grocery stores, pharmacies, gas stations these sources of fundamental supplies will continue to operate.

There is no need to run out and hoard food, gas or medicine, he said. Buy what you need, within reason. There is enough to go around as long as people do not hoard. We will never shut these services down.

The governor made that statement at his daily COVID-19 briefing in Chicago, where he also announced the three deaths, a Will County resident in his 50s, a Cook County resident in her 80s and an out-of-state resident in her 70s who was in Sangamon County bringing the states confirmed death count to four.

He also announced temporary tax relief for some bar and restaurant owners and cautioned that a shutdown of schools could last longer than a March 31 scheduled reopen date.

I also think that parents should be contemplating the possibility that that might be extended, he said of the scheduled March 31 return date.

Pritzker also said the state is evaluating every day as to whether a shelter-in-place order might be necessary, as, he said, experts are advising, this is going to take longer than people have expected.

Pritzker said the effort is largely aimed at staying ahead of countries like Italy, where there are more than 40,000 confirmed cases and more than 3,400 deaths. Social distancing, or staying home, remains the most important preventative measure.

So when I make decisions about this, this is about how do we operate faster and better than Italy and other countries that have seen this grow exponentially for a very long period of time, he said, noting that lack of testing means an increased reliance on mathematicians extrapolating available data over the entire population.

And Im gonna continue to listen to the experts to do the right thing, that the triggers are really in what the experts are seeing, he said.

Chicago Mayor Lori Lightfoot ordered Thursday that any city resident confirmed as having or showing symptoms of COVID-19 must stay home or risk a citation. The suburban village of Oak Park issued a shelter-in-place order which starts Friday, but it allowed for several exemptions, including obtaining essential services such as grocery shopping or medical care.

Pritzker also said the number of confirmed cases now at 422 will continue to grow as testing ramps up. According to the Illinois Department of Public Healths new website, coronavirus.illinois.gov, a total of 3,151 people had been tested in the state as of Thursday.

The states capacity for testing has increased from about 200 people per day to more than 1,000 on Wednesday, Pritzker said, adding it will be two-plus thousand in the next few days.

But, he said, the expected increase in coronavirus cases is also due to the virus spread, not just the increase in testing. He said the virus can also be spread by people who have it but have not been tested or have not shown symptoms.

So we know this is growing substantially. And until there are more and more tests, we will be in this situation of just seeing the numbers rise because the testing is rising, Pritzker said. We hope that there will be a cresting. In some countries in Asia, theres been a cresting because theyve implemented some of the measures that we have implemented here. Weve done it earlier here, but that doesnt mean that were not going to see a lot of cases of COVID-19, and frankly more deaths.

Dr. Ngozi Ezike, IDPH director, said expansion of private testing labs will allow the agency to continue to target its testing at the most vulnerable populations, such as nursing home patients and the staff that care for them.

Pritzker said he called up members of the National Guard to help set up drive-thru testing sites among other logistical and transportation efforts.

The Guard is also doing critical work planning for the weeks and months ahead, including expanding our health care capacity by potentially refitting and reopening previously closed hospitals, he said.

In terms of concrete action in response to the virus Thursday, Pritzker signed another executive order relaxing insurance rules for telemedicine, which allows patients to see a doctor remotely, such as through a video call.

For Medicaid plans and those regulated by the Illinois Department of Insurance, the executive order calls for providers to be reimbursed at the same rate at which they are reimbursed for in-person visits, among other regulatory changes.

This order will allow more providers to get reimbursed for these services and allow patients more flexibility and safety in getting the medical guidance and care that they need, he said.

Pritzker said his staff also worked with grocery stores and retail industry advocates to implement senior shopping hours.

In economic action, Pritzker said he directed the Department of Revenue to defer sales tax payments for small- and medium-sized bars and restaurants that paid less than $75,000 in sales tax last year. Those businesses will not be charged late payment penalties or interest on payments due in March, April or May.

He also announced that the U.S. Small Business Administration has approved the states eligibility in all 102 counties for disaster assistance loans up to $2 million for small businesses facing financial hardship.

Read the original:
Deaths climb to 4 in Illinois, Pritzker says grocery stores, interstates will never shut down - Alton Telegraph

Read More...

Morbidity and mortality associated with gun violence in the United States – 2 Minute Medicine

March 20th, 2020 8:50 pm

1. Firearm use and related crime rates, deaths and injuries have increased disproportionately in the United States compared to other high-income countries over the last decade.

2. Firearm related violence is associated with significant financial, psychosocial and physical harm to communities.

3. Individual and community-level preventative efforts around firearm-related violence and a greater awareness of related implications of firearm use are warranted in the United States and globally.

Study Rundown: Firearm usage, crime rates, related deaths and injuries have significantly increased in the United States over the last decade. Compared to other high income countries, firearm-related death rates were over 11-fold higher in the United States compared to 28 other high-income countries in 2015, with disproportionately higher rates of firearm deaths, firearm homicides, public mass shootings, and both civilian and police deaths in encounters. Firearm suicide rates were higher in rural settings, among men and older adults, and among White communities compared to Black communities. In comparison, firearm homicide victimization rate were higher in urban settings, among Black communities compared to White communities, among men, and ages 20 to 24 years.

While data on firearm related fatalities is generally reliable, data on non-fatal shootings through the Centers for Disease Control is less reliable in the United States. Similarly, crime-related gun use estimates are likely underestimated.

Apart from death and injuries, firearms and exposure to violence also contribute towards other problems and related costs. These include an increased risk of psychiatric (e.g. post-traumatic stress disorder, depression, anxiety and others), emotional (e.g. withdrawal, anger, nervousness and despair), behavioral (e.g. substance abuse, violence, poor academic performance, promiscuous behavior) and health complications (e.g. asthma, heart disease and others). Community-level costs related to firearm injuries and deaths through Medicaid, insurance premiums and uncompensated debt, as well as those related to criminal law enforcement and downstream consequences of high crime communities may be considered. National medical costs of initial hospitalizations for firearm injury have been estimated close to $750 million per year, and do not account for significant hospital-related expenditures and high re-admission rates with related complications.

This review identifies the United States as an outlier in terms of firearm related morbidity and mortality, and related financial, psychosocial and health related sequelae for victims, perpetrators and communities. The findings call for individual and community-level preventative efforts around firearm related violence and a greater awareness of their related implications in the United States and globally.

Click to read the study in Current Trauma Reports

Relevant reading: Global Mortality From Firearms: 1960-2016

Image: PD

20202 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from2 Minute Medicine, Inc. Inquire about licensinghere. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Read more from the original source:
Morbidity and mortality associated with gun violence in the United States - 2 Minute Medicine

Read More...

New Research Among People Living With Rheumatoid Arthritis Reveals Key Determinants Of Patient Satisfaction With Doctors – Monterey County Weekly

March 20th, 2020 8:48 pm

SAN FRANCISCO, March 20, 2020 /PRNewswire/ --MyHealthTeams, creator of the largest and fastest-growing social networks for people facing chronic health conditions, today unveiled new research conducted among registered members of myRAteam, the social network for people living with rheumatoid arthritis (RA). Key findings spanned topics including patient satisfaction with their doctors, the impact RA has on quality of life, and common symptoms and flare-up triggers.

"Joint pain is just the tip of the iceberg for those living with rheumatoid arthritis. You've got to treat the whole person, not just their obvious symptoms," said Eric Peacock, cofounder and CEO of MyHealthTeams. "RA patients in this research made it clear that the best rheumatologists are those who take the time to truly understand the full range of symptoms and the quality of life impact people with RA are experiencing. The gap between patients satisfied and dissatisfied with their doctors was stark."

Patient Satisfaction: Determined by listening/understanding, time spent, and breadth of discussionThere is a high correlation between treatment satisfaction and doctor satisfaction, so if treatment isn't working to control a patient's RA, it's unlikely she will be satisfied with her doctor. But treatment effectiveness isn't the only driver. The study revealed a significant experience gap between those who are satisfied or not with their doctors. Among the 57% of RA patients who report overall satisfaction with their doctors: 87% feel their doctor listens to them and understands their needs; 81% believe their doctor spends enough time with them; 74% report their doctor addresses symptoms such as pain, depression and anxiety; 65% discuss treatment side effects with their doctor; and 52% say their doctor has worked with them to develop a long-term plan. Among the 43% of RA patients who report overall dissatisfaction with their doctors, these numbers drop to 24%, 26%, 20%, 29% and 12% respectively.

Impact on Quality of Life: Daily challenges and emotional impacts take toll at home, work and beyond RA, a chronic inflammatory condition in which the body's immune system attacks its own tissue, including joints, has wide-ranging impact on quality of life.

Further, the emotional toll of RA is significant.

Symptoms and Triggers: Aggravated by environmental factors, disease causes symptoms well beyond joint pain and stiffnessBeyond the joint pain and stiffness experienced by nearly everyone surveyed, myRAteam members report a broad spectrum of symptoms, including:

The top reported triggers for flare-ups of RA symptoms are stress (79%) and cold weather (73%).

This research was conducted among registered members of myRAteam. 374 individuals responded to the online survey. Full survey findings are available at https://www.myrateam.com/resources/the-results-are-in-people-living-with-rheumatoid-arthritis-are-more-satisfied-with-their-doctors-when-they-feel-heard-and-understood

About MyHealthTeamsMyHealthTeamsbelieves that if you are diagnosed with a chronic condition, it should be easy to find and connect with others like you. MyHealthTeams creates social networks for people living with a chronic health condition. Millions of people have joined one of the company's 35 highly engaged communities focusing on the following conditions: Crohn's and colitis, multiple sclerosis, lupus, fibromyalgia, pulmonary hypertension, spondylitis, eczema, myeloma, hyperhidrosis, vitiligo, rheumatoid arthritis, psoriasis, leukemia, lymphoma, irritable bowel syndrome, Parkinson's, Alzheimer's, epilepsy, hemophilia, hidradenitis suppurative, depression, heart disease, type 2 diabetes, osteoporosis, COPD, chronic pain, migraines, food allergies, obesity, HIV, PCOS, endometriosis, breast cancer and autism. MyHealthTeams' social networks are available in 13 countries.

Read this article:
New Research Among People Living With Rheumatoid Arthritis Reveals Key Determinants Of Patient Satisfaction With Doctors - Monterey County Weekly

Read More...

Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial – DocWire…

March 20th, 2020 8:48 pm

INTRODUCTION:

The objective of this study was to assess efficacy and safety of repository corticotropin injection (RCI) in subjects with activerheumatoid arthritis(RA) despite treatment with a corticosteroid and one or two disease-modifying antirheumatic drugs (DMARDs).

All subjects received open-label RCI (80 U) twice weekly for 12weeks (part 1); only those with low disease activity [LDA; i.e., Disease Activity Score 28 joint count and erythrocyte sedimentation rate (DAS28-ESR)<3.2] were randomly assigned to receive either RCI (80 U) or placebo twice weekly during the 12-week double-blind period (part 2). The primary efficacy endpoint was the proportion of subjects who achieved LDA at week 12. Secondary efficacy endpoints included proportions of subjects who maintained LDA during weeks 12 through 24 and achieved Clinical Disease Activity Index (CDAI)10 at weeks 12 and 24. Safety was assessed via adverse event reports.

Of the 259 enrolled subjects, 235 completed part 1; 154 subjects (n=77 each for RCI and placebo) entered part 2, and 127 (RCI, n=71; placebo, n=56) completed. At week 12, 163 subjects (62.9%) achieved LDA and 169 (65.3%) achieved CDAI10 (both p<0.0001). At week 24, 47 (61.0%) RCI-treated and 32 (42.1%) placebo-treated subjects maintained LDA (p=0.019); 66 (85.7%) RCI-treated and 50 (65.8%) placebo-treated subjects maintained CDAI10 (p=0.004). No unexpected safety signals were observed.

RCI was effective and generally safe in patients with active RA despite corticosteroid/DMARD therapy. By week 12,>60% of patients achieved LDA, which was maintained with 12 additional weeks of treatment. Most patients who achieved LDA maintained it for 3months after RCI discontinuation.

Clinicaltrials.gov identifierNCT02919761.

See more here:
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial - DocWire...

Read More...

Relationship between disease activity of rheumatoid arthritis and development of locomotive syndrome: A five-year longitudinal cohort study – DocWire…

March 20th, 2020 8:48 pm

OBJECTIVE:

This study aimed to longitudinally evaluate the association betweenrheumatoid arthritis(RA) and locomotive syndrome (LS) in RA patients using the 25-question Geriatric Locomotive Function Scale (GLFS-25).

Subjects were 58 RA patients (female, 48 (82.8%); mean age, 60.910.9 years) who had GLFS-25 scores available for five consecutive years and who did not have LS at baseline (i.e., GLFS-25<16 points). Associations between DAS28-CRP and the development of LS were determined using linear regression analysis and receiver operating characteristic (ROC) curve analysis.

Subjects were divided into the LS group (n=15, GLFS-2516 points) and Non-LS group (n=43, GLFS-25<16 points) based on GLFS-25 scores at the 5th year of the study period. In the LS group, DAS28-CRP worsened every year. The linear regression model adjusted for age and sex revealed that GLFS-25 increased by 3.80 (95% confidence interval: 1.81-5.79) each time DAS28-CRP increased by 1 (p<0.001). Among patients in remission (DAS28-CRP <2.3), 13.5% had LS. ROC curve analysis yielded a five-year mean DAS28-CRP of 1.99 (sensitivity, 86.7%; specificity, 62.8%) as the cut-off point for the development of LS.

Tight control of RA disease activity for deeper remission may be needed to prevent the development of LS.

Read the rest here:
Relationship between disease activity of rheumatoid arthritis and development of locomotive syndrome: A five-year longitudinal cohort study - DocWire...

Read More...

Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices -…

March 20th, 2020 8:48 pm

OBJECTIVE:

The aim of this study was to evaluate the discriminant capability of the Patient Acceptable Symptom State (PASS) according to disease activity, remission/low disease activity indices and quality of life indices in patients withpsoriatic arthritis(PsA).

Consecutive patients with PsA were enrolled in this cross-sectional study. At each visit, the patients underwent a complete physical examination and their clinical/laboratory data were collected. Disease activity was assessed using the Disease Activity Score forPsoriatic Arthritis(DAPSA) and remission/low disease activity using the DAPSA minimal disease activity (MDA) and very low disease activity (VLDA) criteria. ThePsoriatic ArthritisImpact of Disease (PsAID) and the Health Assessment Questionnaire-Disability Index scores were also collected. Finally, PASS was assessed by asking all patients to answer yes or no to a single question.

Patients who answered yes to PASS showed a significantly better overall mean DAPSA score than those who were not in PASS. Furthermore, patients in PASS showed a significantly lower level of systemic inflammation, lower Leeds Enthesitis Index score, a significantly lower impact of disease (PsAID), lower pain and better function than patients who answered no to PASS. A moderate to good agreement was found between PASS, MDA, DAPSA low disease activity and PsAID score 4. Good sensitivity and specificity were found with PASS with respect to DAPSA low disease activity, and although PASS is sensitive in the identification of patients with MDA, DAPSA remission and VLDA it lacks of specificity.

This study showed that PASS might be used as an alternative to determine disease activity in patients with PsA in real clinical practice, mainly in patients with low disease activity according to DAPSA criteria.

Read this article:
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices -...

Read More...

FDA Approves OTC Combination of Ibuprofen and Acetaminophen for Minor Arthritis Pain – Rheumatology Advisor

March 20th, 2020 8:48 pm

Home Topics Pain Management

The FDA has approved Advil Dual Action with Acetaminophen (GlaxoSmithKline), the first over-the-counter (OTC) fixed-dose combination therapy containing ibuprofen and acetaminophen for the temporary relief of minor aches and pains due to headache, backache, muscular aches, toothache, menstrual cramps, and minor pain of arthritis.

Each caplet contains 125mg of Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) and 250mg of acetaminophen and is indicated for adults and children 12 years of age and older. The approval was based on study data that showed use of the fixed-dose combination therapy was associated with superior pain relief compared with the individual components taken alone.

Advil Dual Action with Acetaminophen is expected to be available nationwide sometime during 2020.

GlaxoSmithKline recently received FDA approval for another OTC pain reliever, Voltaren Arthritis Pain (diclofenac topical gel), for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults 18 years old. The OTC formulation is the same as the prescription strength (10mg of diclofenac sodium per gram or 1%). It is expected to be available in spring 2020.

For more information visit gsk.com.

This article originally appeared on MPR

Please login or register first to view this content.

LoginRegister

Next post in Pain ManagementClose

Go here to see the original:
FDA Approves OTC Combination of Ibuprofen and Acetaminophen for Minor Arthritis Pain - Rheumatology Advisor

Read More...

Rheumatoid Arthritis Treatment Market Share, Size, Future Demand, Global Research, Top Leading Player, Emerging Trends and Forecast to 2029 – Daily…

March 20th, 2020 8:48 pm

The Rheumatoid Arthritis Treatment Market study offers an in-depth analysis of the current market trends influencing this business vertical. The study also includes market valuation, market size, revenue forecasts, geographical spectrum and SWOT Analysis of the industry. In addition, the report depicts key challenges and growth opportunities faced by the industry bigwigs, in consort with their product offerings and business strategies.

A collective analysis of Rheumatoid Arthritis Treatment Market offering an exhaustive study based on current trends influencing this vertical across various geographies has been provided in the report. Also, this research study estimates this space to accrue considerable income during the projected period, with the help of a plethora of driving forces that will boost the industry trends during the forecast duration. Snippets of these influences, in tandem with countless other dynamics relating to the Rheumatoid Arthritis Treatment Market, like the risks that are predominant across this industry along with the growth prospects existing in Rheumatoid Arthritis Treatment Market, have also been charted out in the report.

ThisPress Release will help you to understand the Volume, growth with Impacting Trends. Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) at https://www.xploremr.com/connectus/sample/2263

The report covers exhaustive analysis on:

Regional analysis includes

Get Your Copy at a Discounted Rate!!! Limited Time Offer!!! https://www.xploremr.com/connectus/check-discount/2263

The report provides extensive data concerning the market share that each one of these companies presently gather throughout this business, followed by the market share that they are anticipated to acquire by the end of the predicted timeframe. Also, the report expounds on details relating to the goods manufactured by these firms, that would help new industry participants and major stakeholders work on their competition and portfolio strategies. In addition, their policymaking process is likely to get easier since the Rheumatoid Arthritis Treatment Market report also enumerates an idea of the trends in product prices and the revenue margins of all the major companies partaking in the industry share.

Queries that the Rheumatoid Arthritis Treatment Market report answers in respect of the regional landscape of the business domain:

Get Full Report Access athttps://www.xploremr.com/cart/2263/SL

Significant takeaways from the study:

The Rheumatoid Arthritis Treatment Market report hosts excess deliverables that may be highly advantageous. Say for instance, the report emphasizes information regarding market competition trends extremely essential data subject to contender intelligence and the current industry drifts that would enable shareholders to compete and take advantage of the biggest growth opportunities in the Rheumatoid Arthritis Treatment Market.

Another vital takeaway from the report can be accredited to the industry concentration rate that could help stakeholders to speculate on the existing sales dominance and the probable trends of the forthcoming years.

Additional deliverables mentioned in the report include details pertaining to the sales channels deployed by prominent sellers in order to retail their status in the industry, including direct and indirect marketing.

About Us

XploreMR is one of the worlds leading resellers of high-quality market research reports. We feature in-depth reports from some of the worlds most reputed market research companies and international organizations. We serve across a broad spectrum from Fortune 500 to small and medium businesses. Our clients trust us for our unwavering focus onquality and affordability. We believe high price should not be a bottleneck for organizations looking to gain access to quality information.

Contact us:

XploreMR111 North Market Street, Suite 300,San Jose, CA 95113, United StatesPh.No: +16692840108E-mail id-[emailprotected]Web-https://www.xploremr.com

Read the original:
Rheumatoid Arthritis Treatment Market Share, Size, Future Demand, Global Research, Top Leading Player, Emerging Trends and Forecast to 2029 - Daily...

Read More...

Rheumatoid Arthritis Diagnosis Tests Market expected to Witness a Sustainable Growth over 2017 2025 – Feed Road

March 20th, 2020 8:48 pm

Rheumatoid Arthritis Diagnosis Tests Market size will reach xx million US$ by 2029, from xx million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and2017 2025 as the forecast period to estimate the market size for Rheumatoid Arthritis Diagnosis Tests.

This industry study presents the Rheumatoid Arthritis Diagnosis Tests Market size, historical breakdown data 2014-2019 and forecast 2017 2025. The Private Plane production, revenue and market share by manufacturers, key regions and type; The consumption of Rheumatoid Arthritis Diagnosis Tests Market in volume terms are also provided for major countries (or regions), and for each application and product at the global level.

ThisPress Release will help you to understand the Volume, growth with Impacting Trends. Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) at https://www.xploremr.com/connectus/sample/336

Rheumatoid Arthritis Diagnosis Tests Market report coverage:

The Rheumatoid Arthritis Diagnosis Tests Market report covers extensive analysis of the market scope, structure, potential, fluctuations, and financial impacts. The report also enfolds the precise evaluation of market size, share, product & sales volume, revenue, and growth rate. It also includes authentic and trustworthy estimations considering these terms.

The Rheumatoid Arthritis Diagnosis Tests Market has been reporting substantial growth rates with considerable CAGR for the last couple of decades. According to the report, the market is expected to grow more vigorously during the forecast period and it can also influence the global economic structure with a higher revenue share. The market also holds the potential to impact its peers and parent market as the growth rate of the market is being accelerated by increasing disposable incomes, growing product demand, changing consumption technologies, innovative products, and raw material affluence.

The study objectives are Rheumatoid Arthritis Diagnosis TestsMarket Report:

In this study, the years considered to estimate the market size of Rheumatoid Arthritis Diagnosis TestsMarket:

History Year: 2014 2018

Base Year: 2018

Estimated Year: 2019

Forecast Year:2017 2025

This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Rheumatoid Arthritis Diagnosis Tests Market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get Your Copy at a Discounted Rate!!! Limited Time Offer!!! https://www.xploremr.com/connectus/check-discount/336

The report covers exhaustive analysis on:

Regional analysis includes

Get Full Report Access athttps://www.xploremr.com/cart/336/SL

Benefits of Purchasing from XMR:

About Us

XploreMR is one of the worlds leading resellers of high-quality market research reports. We feature in-depth reports from some of the worlds most reputed market research companies and international organizations. We serve across a broad spectrum from Fortune 500 to small and medium businesses. Our clients trust us for our unwavering focus onquality and affordability. We believe high price should not be a bottleneck for organizations looking to gain access to quality information.

Contact us:

XploreMR111 North Market Street, Suite 300,San Jose, CA 95113, United StatesPh.No: +16692840108E-mail id-[emailprotected]Web-https://www.xploremr.com

Read the original here:
Rheumatoid Arthritis Diagnosis Tests Market expected to Witness a Sustainable Growth over 2017 2025 - Feed Road

Read More...

Fight Inflammation With Tart Cherry Juice – Newsmax

March 20th, 2020 8:48 pm

Tart cherry juice is the latest health rage and for good reason. The cancer-fighting beverage may also protect against heart disease, reduce arthritis symptoms, and help you sleep more soundly.

"Tart cherries are loaded with important nutrients, but you'd have to eat an entire bag of them to obtain all the benefits you get by sipping the juice," says Michele Turcotte, M.S., R.D., a dietitian and nutritionist in Lake Geneva, Wisconsin. "Its juice contains many antioxidants and anti-inflammatory agents, which can help alleviate a variety of ailments like asthma symptoms and pain."

Turcotte explains that tart cherries, like all red fruits and vegetables, are rich in anthocyanins, a particularly potent antioxidant phytochemical.

"Anthocyanins encourage healthy circulation, ensure proper nerve function, and offer cancer-fighting properties," says the expert. A research study published in the Journal of Nutrition says that tart cherry juice provides older adults great protection against the development of heart disease, cancer and age-related cognitive decline.

Here are more health benefits:

* Heart disease and diabetes. The quercetin found in tart cherry juice is another powerful antioxidant that helps prevent free radical damage caused by low-density lipoprotein or LDL, according to a 2013 study. When LDL cholesterol is oxidized, its more likely to stick to arterial walls, forming plaque that contributes to heart attack and stroke.

Another study published in the International Journal of Preventative Medicine noted that intake of high levels of quercetin were associated with reduced risk of type 2 diabetes.

* Insomnia. Drinking an 8-ounce glass of tart cherry juice in the morning and the evening may be a better and safer way to treat insomnia than taking drugs, according to researchers at Louisiana State University. Tart cherries are a natural source of melatonin, a hormone that helps regulate the sleep-wake cycle.

* Sports recovery and muscle damage. Marathon runners who consumed 8 ounces of tart cherry juice twice daily for five days prior to a marathon, on the day of the marathon, and then for two days afterward reported less muscle damage, soreness, inflammation, and protein breakdown than runners who consumed a placebo, according to research published in the Scandinavian Journal of Medicine and Science in Sports.

* Arthritis and gout. Tart cherry juice may reduce arthritis symptoms such as joint pain and inflammation, according to several studies. A 2012 study revealed that folks with osteoarthritis who drank tart cherry juice for 21 days had reduced symptoms of pain.

* Brain health. Since degenerative brain disorders like Parkinson's and Alzheimer's are thought to be causeed, in part, by oxidative stress, drinking tart cherry juice may have protective effects on brain cells. In fact, in one study, older adults with mild-to-moderate cognitive decline consumed 6 ounces of tart cherry juice daily or a placebo for 12 weeks. The adults in the tart cherry juice group experienced improvement in verbal fluency, short term memory, and long-term memory, whereas the placebo group experienced no improvement.

2020 NewsmaxHealth. All rights reserved.

Read the rest here:
Fight Inflammation With Tart Cherry Juice - Newsmax

Read More...

Lessons from cancer patients in the time of coronavirus – Fred Hutch News Service

March 20th, 2020 8:47 pm

SCCA psychiatrist Dr. Nicole Bates, who splits her time between patients with cancer and those without, said uncertainty can either demoralize or empower people. Some cancer patients, she said, become depressed or anxious, while others develop incredible resilience.

So many of us are grappling with the initial affront and lack of control, she said, regarding the current crisis. Ive been struck by how my patients find strength through uncertainty, how they use it to crystallize priorities for living each day.

Fred Hutch psychologist and patient outcomes researcher Dr. Salene Jones described resilience as the ability to adapt to stressful events.

A person can be sad, unhappy or stressed, and still, ultimately, be resilient, she said, pointing to resiliency tips recently published by the American Psychological Association. Resilience is not the absence of feeling stressed but finding a way to cope with it. Its OK to be a mess sometimes. Just not all the time.

Cancer patients have also been staying connected, while apart, for years.

#BCSM (short for breast cancer social media) holds weekly Twitter chats, drawing patients and survivors from around the world. Ditto for other patient communities on Twitter, including for brain cancer, lung cancer, pancreatic cancer and many more. People living with disease also regularly gather in closed Facebook groups or vast online patient communities like Inspire, Smart Patients, Colontown and others to ask for advice, grouse about side effects and gain strength from others.

Its easy to become isolated and lonely, said Renee Kaiman, a 38-year-old metastatic breast cancer patient and mother of two from Toronto, Canada. Right now, its good to reach out to people via FaceTime or have phone calls. Try to do things you enjoy to keep your mood up.

Staying connected with yourself is also key, especially when dealing with isolation and angst.

This is a great time to explore creative projects, to listen to music, to try new recipes theyve never tried before, Kleinhofer said. We cant control whats happening right now, but we can control how we respond to it. Things may seem crazy but every day theres something to be thankful for. Find what makes you happy and focus on that, whether its family or friends or the sound of birds chirping outside. And if you start to spin out of control, thats when yoga, meditation and mindfulness can come into play.

More here:
Lessons from cancer patients in the time of coronavirus - Fred Hutch News Service

Read More...

Page 645«..1020..644645646647..650660..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick